Use of raloxifene for preparing medicine for treating, fibroid and endometriosis
OA: closed
Abstract
The invention refers to the prevention and cure of hystero myoma and the treatment of endometriosis. Give Raloxifen or its salt receivable in medicine about 30-150mg/day to women suffering from myoma of uterus, to prohibit the development of hystero myoma. Give Raloxifen or its salt receivable in medicine about 30-150mg/day to women in procreating period, to relieve the symptom of endometriosis.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-08T06:14:57.058073+00:00